REFERENCES
1. Pozniak A, Bull T. Recently recognized mycobacteria of clinical significance. J Infect. 1999;38(3):157-61.
2. Jarzembowski JA, Young MB. Nontuberculous mycobacterial infections. Arch Pathol Lab Med. 2008;132(8):1333-41.
3. Martinez S, McAdams HP, Batchu CS. The many faces of pulmonary nontuberculous mycobacterial infection. Am J Roentgenol. 2007;189(1):177-86.
4. Wolfe J, Turenne C, Alfa M, Harding G, Thibert L, Kabani A. Mycobacterium branderi from both a hand infection and a case of pulmonary disease. J Clin Microbiol. 2000;38(10):3896-9.
5. Chetchotisakd P, Mootsikapun P, Anunnatsiri S, Jirarattanapochai K, Choonhakarn C, Chaiprasert A, et al. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. J Clin Infect Dis. 2000;30(1):29-34.
6. Springer B, Kirschner P, Rost-Meyer G, Schröder K, Kroppenstedt R, Böttger E. Mycobacterium interjectum, a new species isolated from a patient with chronic lymphadenitis. J Clin Microbiol. 1993;31(12):3083-9.
7. Wallace Jr RJ, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis. 1992;166(2):405-12.
8. Woo PC, Li JH, Tang WW, Yuen KY. Acupuncture mycobacteriosis. NEJM. 2001;345(11):842-3.
9. Raad II, Vartivarian S, Khan A, Bodey GP. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis. 1991;13(6):1120-5.
10. Schinsky MF, McNeil MM, Whitney AM, Steigerwalt AG, Lasker BA, Floyd MM, et al. Mycobacterium septicum sp. nov., a new rapidly growing species associated with catheter-related bacteraemia. Int J Syst Evol Microbiol. 2000;50(2):575-81.
11. Kiska DL, Turenne CY, Dubansky AS, Domachowske JB. First case report of catheter-related bacteremia due to “Mycobacterium lacticola”. J Clin Microbiol. 2004;42(6):2855-7.
12. Vera G, Lew SQ. Mycobacterium fortuitum peritonitis in two patients receiving continuous ambulatory peritoneal dialysis. Am J Nephrol. 1999;19(5):586-9.
13. Griffith DE, Brown-Elliott BA, L. Benwill J, Wallace Jr RJ. Mycobacterium abscessus.“Pleased to meet you, hope you guess my name…”. Ann Am Thorac Soc. 2015;12(3):436-9.
14. Tortoli E, Kohl TA, Brown-Elliott BA, Trovato A, Leão SC, Garcia MJ, et al. Amended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacteriumabscessus subsp. bolletii and designation of Mycobacteriumabscessus subsp. massiliense comb. Int J Syst Evol Microbiol. Nov 2016;66(11):4471-9.
15. Snydman DR, Redelman-Sidi G, Sepkowitz KA. Rapidly growing mycobacteria infection in patients with cancer. J Clin Infect Dis. 2010;51(4):422-34.
16. Chan WYK LP, Chiang AKS, Cheuk KLD, Ha SY, Ho PL. Clinical Characteristics and Outcomes of Paediatric Non-tuberculous Mycobacterial Infection – Single institution retrospective review over 20 years and literature review. HK J Paediatr [In press].
17. Lindeboom JA, Kuijper EJ, Bruijnesteijn van Coppenraet ES, Lindeboom R, Prins JM. Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. J Clin Infect Dis. 2007;44(8):1057-64.
18. Sizaire V, Nackers F, Comte E, Portaels F. Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis. 2006;6(5):288-96.
19. Bermudez LE, Kolonoski P, Petrofsky M, Wu M, Inderlied CB, Young LS. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease. J Infect Dis. 2003;187(12):1977-80.
20. Harausz EP, Garcia-Prats AJ, Seddon JA, Schaaf HS, Hesseling AC, Achar J, et al. New and repurposed drugs for pediatric multidrug-resistant tuberculosis. Practice-based recommendations. Am J Respir Crit Care Med. 2017 May 15;195(10):1300-1310.